These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 28216442)

  • 1. A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.
    Fox MT; Melia MT; Same RG; Conley AT; Tamma PD
    Am J Med; 2017 Jul; 130(7):842-845. PubMed ID: 28216442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
    Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
    Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.
    Talan DA; Krishnadasan A; Abrahamian FM; Stamm WE; Moran GJ;
    Clin Infect Dis; 2008 Nov; 47(9):1150-8. PubMed ID: 18808361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
    Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
    J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.
    Gomolin IH; Siami PF; Reuning-Scherer J; Haverstock DC; Heyd A;
    J Am Geriatr Soc; 2001 Dec; 49(12):1606-13. PubMed ID: 11843992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.
    Talan DA; Stamm WE; Hooton TM; Moran GJ; Burke T; Iravani A; Reuning-Scherer J; Church DA
    JAMA; 2000 Mar 22-29; 283(12):1583-90. PubMed ID: 10735395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient antibiogram and predictors of ciprofloxacin and trimethoprim-sulfamethoxazole resistant urinary tract infections.
    Valentine-King M; Zoorob R; Grigoryan L; Trautner B
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36944052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Trimethoprim and Sulfamethoxazole-Resistant Escherichia Coli in ED Patients with Urinary Tract Infections.
    Wesolek JL; Wu JY; Smalley CM; Wang L; Campbell MJ
    Am J Emerg Med; 2022 Jun; 56():178-182. PubMed ID: 35405469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source.
    Sutton JD; Stevens VW; Chang NN; Khader K; Timbrook TT; Spivak ES
    JAMA Netw Open; 2020 Oct; 3(10):e2020166. PubMed ID: 33030555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy.
    Perfetto EM; Keating K; Merchant S; Nichols BR
    J Manag Care Pharm; 2004; 10(1):17-25. PubMed ID: 14720102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
    Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
    Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection.
    Stuck AK; Täuber MG; Schabel M; Lehmann T; Suter H; Mühlemann K
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1359-63. PubMed ID: 22232276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritis.
    Mouton Y; Ajana F; Chidiac C; Capron MH; Home P; Masquelier AM
    Am J Med; 1992 Apr; 92(4A):87S-90S. PubMed ID: 1316078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic resistance in isolates recovered from women with community-acquired urinary tract infections presenting to a tertiary care emergency department.
    Filiatrault L; McKay RM; Patrick DM; Roscoe DL; Quan G; Brubacher J; Collins KM
    CJEM; 2012 Sep; 14(5):295-305. PubMed ID: 22967697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing adherence to evidence-based guidelines for the diagnosis and management of uncomplicated urinary tract infection.
    Grover ML; Bracamonte JD; Kanodia AK; Bryan MJ; Donahue SP; Warner AM; Edwards FD; Weaver AL
    Mayo Clin Proc; 2007 Feb; 82(2):181-5. PubMed ID: 17290725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis.
    Colgan R; Johnson JR; Kuskowski M; Gupta K
    Antimicrob Agents Chemother; 2008 Mar; 52(3):846-51. PubMed ID: 18086847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
    Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W;
    Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comeback of trimethoprim in France.
    Caron F; Wehrle V; Etienne M
    Med Mal Infect; 2017 Jun; 47(4):253-260. PubMed ID: 28043762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group.
    McCarty JM; Richard G; Huck W; Tucker RM; Tosiello RL; Shan M; Heyd A; Echols RM
    Am J Med; 1999 Mar; 106(3):292-9. PubMed ID: 10190377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection: A Randomized Clinical Trial.
    Drekonja DM; Trautner B; Amundson C; Kuskowski M; Johnson JR
    JAMA; 2021 Jul; 326(4):324-331. PubMed ID: 34313686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.